Literature DB >> 32279710

Treatment of Nonmotor Symptoms Associated with Parkinson Disease.

Jennifer G Goldman1, Carlos Manuel Guerra2.   

Abstract

Parkinson disease (PD) is well recognized by its motor features of bradykinesia, tremor, rigidity, and gait and balance difficulties. However, PD is also characterized by a myriad of nonmotor symptoms, which may occur even before motor symptoms, early in the course of disease, and throughout the advancing disease. These nonmotor symptoms span multiple different systems, invoke multiple different neurotransmitters, and require multiple strategies for treatment including pharmacologic and nonpharmacologic interventions and, often, multiple different disciplines. This article discusses symptoms, assessments, and therapeutics for the nonmotor symptoms of PD including those affecting mood, cognition, behavior, sleep, autonomic function, and sensory systems.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Apathy; Autonomic symptoms; Cognition; Dementia; Depression; Psychosis; Sensory symptoms

Year:  2020        PMID: 32279710     DOI: 10.1016/j.ncl.2019.12.003

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  8 in total

Review 1.  Role of Environmental Toxicants on Neurodegenerative Disorders.

Authors:  Masarat Nabi; Nahida Tabassum
Journal:  Front Toxicol       Date:  2022-05-11

2.  High-quality nursing intervention can improve negative emotions, quality of life and activity of daily living of elderly patients with Parkinson's disease.

Authors:  Yihui Gui; Youya Zhou
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.

Authors:  Hua Cao; Xinsheng Han; Yonglin Jia; Baohua Zhang
Journal:  Aging (Albany NY)       Date:  2021-04-04       Impact factor: 5.682

4.  Acupuncture in the treatment of fatigue in Parkinson's disease: A protocol for systematic review and meta-analysis.

Authors:  Yingpeng Zhi; Chen Gao
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

5.  The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study.

Authors:  Nobutaka Hattori; Yuki Kogo; Michinori Koebis; Takayuki Ishida; Ippei Suzuki; Yoshio Tsuboi; Masahiro Nomoto
Journal:  Front Neurol       Date:  2022-02-07       Impact factor: 4.003

Review 6.  Sudden unexpected death in Parkinson's disease: Insights from clinical practice.

Authors:  Fulvio A Scorza; Marcia Guimarães-Marques; Mariana Nejm; Antônio Carlos G de Almeida; Carla A Scorza; Ana C Fiorini; Josef Finsterer
Journal:  Clinics (Sao Paulo)       Date:  2022-02-10       Impact factor: 2.365

7.  Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice.

Authors:  Rui-Chen Xu; Wen-Teng Miao; Jing-Yi Xu; Wen-Xin Xu; Ming-Ran Liu; Song-Tao Ding; Yu-Xin Jian; Yi-Han Lei; Ning Yan; Han-Deng Liu
Journal:  Nutrients       Date:  2022-10-07       Impact factor: 6.706

8.  A Multiscale, Systems-Level, Neuropharmacological Model of Cortico-Basal Ganglia System for Arm Reaching Under Normal, Parkinsonian, and Levodopa Medication Conditions.

Authors:  Sandeep Sathyanandan Nair; Vignayanandam Ravindernath Muddapu; V Srinivasa Chakravarthy
Journal:  Front Comput Neurosci       Date:  2022-01-03       Impact factor: 2.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.